| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 5863-10 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-6 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-7 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-8 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-9 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-16 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-17 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-18 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-19 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-20 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-26 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-27 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-28 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-29 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-30 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-1 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-2 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-3 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-4 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-5 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-11 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-12 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-13 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-14 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-15 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-21 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-22 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-23 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-24 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase NEGATIVE ION MODE | 5863-25 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
Return to study ST000649 main page
Download data matrix(Effects of NO Donor Therapy on the Dystrophic Mouse Muscle Non-Esterified Fatty Acids (part V) Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|